Jun 20
|
Race Oncology engages George Clinical for Phase I solid tumour trial
|
Jul 19
|
Race Oncology announces deal with manufacturer Ardena to develop company’s new IV formulation RC220
|
Jul 12
|
Race executes agreement with Ardena for GMP manufacturing of RC220
|